The SWR documentary “SWR Story” highlights the medical and social hurdles faced by individuals with rare diseases, including the five-year-old Timmon, who lives with the Dup15Q syndrome.
As reported by br.de, the broadcast airs on November 11, 2026, at 21:00 on ARD alpha, detailing the daily struggles of four individuals living with chronic conditions.
Approximately four to five million people in Germany live with one of roughly 8,000 rare diseases. For many, the diagnostic process is an arduous journey, and effective therapies often remain inaccessible. The documentary follows the lives of Timmon; mountaineer Julia Lauer, 31, who is preparing for a Himalaya expedition while managing a neurological condition; and Max Bronnert and Stephan Kruip, both of whom live with cystic fibrosis.
The treatment of cystic fibrosis has been transformed by the medication “Kaftrio,” which offers many patients a new quality of life. However, this therapy costs 200,000 euros per patient annually.
Prof. Bernd Mühlbauer, head of the German Commission for Medicines, raised concerns regarding the pharmaceutical industry’s pricing structures. “There is no industry in the world that generates such golden profit margins,” Mühlbauer stated. “That is why one must clearly demand more price regulation.”
How many people in Germany are affected by rare diseases?
According to the report, there are approximately four to five million people in Germany living with one of the roughly 8,000 identified rare diseases.
What is the focus of the “SWR Story” documentary?
The film examines the everyday lives of four individuals and explores the broader medical and societal challenges associated with rare illnesses.
It specifically addresses the high costs of life-altering medications like Kaftrio.
What regulatory changes have been proposed regarding drug costs?
Prof. Bernd Mühlbauer has publicly called for increased transparency and stricter price regulation within the pharmaceutical industry to address the high costs of specialty treatments.
Keep reading